Tazemetostat Hydrobromide Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2026-03-27 · last update 2026-03-27
Manufacturers: Epizyme, Inc. (An Ipsen Company)
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Tazverik, Tablet, 200 mg (NDC 72607-100-00) | Epizyme, Inc. (An Ipsen Company) | To Be Discontinued | — | Discontinuation of the manufacture of the drug product | Posted 03/27/2026 Updated 03/27/2026 Discontinued 03/27/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)